- Home
- ILMN vs COO Comparison
ILMN vs COO Comparison
Compare ILMN & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- COO
- Stock Information
- Founded
- ILMN 1998
- COO 1980
- Country
- ILMN United States
- COO United States
- Employees
- ILMN N/A
- COO N/A
- Industry
- ILMN Medical Specialities
- COO Ophthalmic Goods
- Sector
- ILMN Health Care
- COO Health Care
- Exchange
- ILMN Nasdaq
- COO Nasdaq
- Market Cap
- ILMN 15.9B
- COO 15.6B
- IPO Year
- ILMN 2000
- COO N/A
- Fundamental
- Price
- ILMN $77.35
- COO $80.89
- Analyst Decision
- ILMN Buy
- COO Buy
- Analyst Count
- ILMN 18
- COO 9
- Target Price
- ILMN $139.50
- COO $110.25
- AVG Volume (30 Days)
- ILMN 2.4M
- COO 2.0M
- Earning Date
- ILMN 05-08-2025
- COO 05-29-2025
- Dividend Yield
- ILMN N/A
- COO N/A
- EPS Growth
- ILMN N/A
- COO 41.73
- EPS
- ILMN N/A
- COO 2.07
- Revenue
- ILMN $4,372,000,000.00
- COO $3,928,500,000.00
- Revenue This Year
- ILMN $0.09
- COO $6.77
- Revenue Next Year
- ILMN $4.71
- COO $6.56
- P/E Ratio
- ILMN N/A
- COO $39.37
- Revenue Growth
- ILMN N/A
- COO 7.15
- 52 Week Low
- ILMN $68.70
- COO $69.81
- 52 Week High
- ILMN $156.66
- COO $112.38
- Technical
- Relative Strength Index (RSI)
- ILMN 47.21
- COO 51.25
- Support Level
- ILMN $69.83
- COO $77.59
- Resistance Level
- ILMN $79.37
- COO $82.84
- Average True Range (ATR)
- ILMN 3.80
- COO 3.10
- MACD
- ILMN 1.19
- COO 0.85
- Stochastic Oscillator
- ILMN 81.07
- COO 85.03
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.